Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Notes Payables (2017 - 2025)

Historic Notes Payables for Ekso Bionics Holdings (EKSO) over the last 11 years, with Q3 2025 value amounting to $1.2 million.

  • Ekso Bionics Holdings' Notes Payables changed 0.0% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.2 million for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Ekso Bionics Holdings reported Notes Payables of $1.2 million as of Q3 2025, which was down 0.0% from $1.2 million recorded in Q2 2025.
  • Ekso Bionics Holdings' Notes Payables' 5-year high stood at $2.9 million during Q2 2023, with a 5-year trough of $814000.0 in Q1 2021.
  • Over the past 5 years, Ekso Bionics Holdings' median Notes Payables value was $1.2 million (recorded in 2023), while the average stood at $1.6 million.
  • As far as peak fluctuations go, Ekso Bionics Holdings' Notes Payables tumbled by 6248.85% in 2021, and later changed by 0.0% in 2024.
  • Ekso Bionics Holdings' Notes Payables (Quarter) stood at $814000.0 in 2021, then skyrocketed by 183.78% to $2.3 million in 2022, then tumbled by 45.89% to $1.2 million in 2023, then changed by 0.0% to $1.2 million in 2024, then changed by 0.0% to $1.2 million in 2025.
  • Its Notes Payables was $1.2 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.2 million in Q1 2025.